ANANDA Scientific Appoints Maypro as U.S. Sales and Distribution Partner
GREENWOOD, Colorado — November 8, 2019 —
ANANDA Scientific today announced the appointment of Maypro Industries, one of the largest global suppliers of nutraceutical ingredients, as the company’s Sales and Distribution Partner in the United States on the heels of SupplySide West in Las Vegas.
“We are thrilled to bring on Maypro as the strategic bulk ingredient sales partner to build out our key distribution channels and launch our pipeline of nutraceutical products,” said Mark J. Rosenfeld, M.S., Ph.D. Chief Executive Officer & Chief Science Officer. “Their depth of experience, credibility and prestigious position in the market as a supplier of premium highly efficacious ingredients will bring a large, established customer base in which to pave the way for broad access to ANANDA’s bio-enhanced products.”
“We are very pleased to be partnering with ANANDA, and we are eager to launch their products to our customer base,” said Steve Yamada, Chairman and Founder of Maypro Industries, who was the recipient of the 2007 Nutrition Business Journal “Lifetime Achievement Award” for his outstanding contribution in the nutritional supplement industry. “We look forward to working together to improve health by supplying products made with safe, natural, highly efficacious nutraceutical ingredients.”
Maypro, founded in 1977, has grown into one of the largest global suppliers of nutraceutical ingredients, with six strategically located companies in the US, Japan and China. The company is known for bringing blockbuster products to market with a highly selective portfolio of innovative proprietary patented and branded ingredients backed by extensive clinical data.
ANANDA is a research-focused biotech company that employs patented delivery technologies to make cannabinoids and other plant derived compounds highly bioavailable, water soluble and shelf-life stable nutraceutical and pharmaceutical products. ANANDA is pursuing clinical trials for pharmaceutical approval that use its technology to address therapeutic targets of tremendous public health importance. On the back of its strong research base, the company has a growing pipeline of nutraceutical over-the-counter products. The company has successfully launched these in the US, UK and EU, with expansion into China, Australia and Africa planned for the near future. The company is expanding its research base through multiple sponsored research agreements with universities to diversify its technology footprint.